Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.
about
First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.Advances in pharmacotherapy for treating female sexual dysfunction.Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.Flibanserin: First Global Approval.A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes.A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada.
P2860
Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hypoactive sexual desire disor ...... ith patients on sexual health.
@ast
Hypoactive sexual desire disor ...... ith patients on sexual health.
@en
Hypoactive sexual desire disor ...... ith patients on sexual health.
@nl
type
label
Hypoactive sexual desire disor ...... ith patients on sexual health.
@ast
Hypoactive sexual desire disor ...... ith patients on sexual health.
@en
Hypoactive sexual desire disor ...... ith patients on sexual health.
@nl
prefLabel
Hypoactive sexual desire disor ...... ith patients on sexual health.
@ast
Hypoactive sexual desire disor ...... ith patients on sexual health.
@en
Hypoactive sexual desire disor ...... ith patients on sexual health.
@nl
P2860
P356
P1433
P1476
Hypoactive sexual desire disor ...... ith patients on sexual health.
@en
P2093
Nicole M Lodise
P2860
P304
P356
10.1002/PHAR.1209
P407
P577
2013-04-01T00:00:00Z